Literature DB >> 6737510

Status epilepticus after baclofen withdrawal.

C L Hyser, M E Drake.   

Abstract

Baclofen is widely used in the treatment of spasticity of spinal origin. It is relatively free of side effects or toxic actions on the nervous system or other organs. Agitation, personality change, and auditory and visual hallucinations have been described following its abrupt withdrawal. One patient with generalized seizures and one with complex partial seizures after baclofen withdrawal have been reported. This paper presents a patient who developed status epilepticus after baclofen withdrawal, and who sustained hypoxic cerebral injury. This observation further emphasizes the possibility of infrequent complications of baclofen therapy, and the advisability of gradual changes in baclofen dosage.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6737510      PMCID: PMC2561766     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  7 in total

1.  The chemistry and kinetics of Lioresal.

Authors:  J W Faigle; H Keberle
Journal:  Postgrad Med J       Date:  1972-10       Impact factor: 2.401

Review 2.  Clinical and experimental aspects of barbiturate withdrawal convulsions.

Authors:  C F Essig
Journal:  Epilepsia       Date:  1967-03       Impact factor: 5.864

3.  Hallucinations after withdrawal of baclofen.

Authors:  A J Lees; C R Clarke; M J Harrison
Journal:  Lancet       Date:  1977-04-16       Impact factor: 79.321

4.  Complications of baclofen withdrawal.

Authors:  C F Terrence; G H Fromm
Journal:  Arch Neurol       Date:  1981-09

5.  Baclofen in spasticity.

Authors: 
Journal:  Lancet       Date:  1977-09-17       Impact factor: 79.321

6.  Baclofen as an anticonvulsant in experimental models of convulsions.

Authors:  M A Benedito; J R Leite
Journal:  Exp Neurol       Date:  1981-05       Impact factor: 5.330

7.  Baclofen for spasticity in multiple sclerosis. Double-blind crossover and three-year study.

Authors:  R G Feldman; M Kelly-Hayes; J P Conomy; J M Foley
Journal:  Neurology       Date:  1978-11       Impact factor: 9.910

  7 in total
  6 in total

1.  Drug points: Neonatal convulsions after withdrawal of baclofen.

Authors:  B D Ratnayaka; H Dhaliwal; S Watkin
Journal:  BMJ       Date:  2001-07-14

2.  Intrathecal baclofen withdrawal syndrome following posterior spinal fusion for neuromuscular scoliosis: a case report.

Authors:  Pedro Fernandes; Lori Dolan; Stuart L Weinstein
Journal:  Iowa Orthop J       Date:  2008

3.  Treatment of pediatric multiple sclerosis.

Authors:  Sona Narula; Sarah E Hopkins; Brenda Banwell
Journal:  Curr Treat Options Neurol       Date:  2015-03       Impact factor: 3.598

Review 4.  Drug deprescription-withdrawal risk, prevention, and treatment.

Authors:  Madison K Bangert; Gabriel M Aisenberg
Journal:  Proc (Bayl Univ Med Cent)       Date:  2019-12-20

Review 5.  Management of children with multiple sclerosis.

Authors:  E Ann Yeh
Journal:  Paediatr Drugs       Date:  2012-06-01       Impact factor: 3.022

Review 6.  Use of Disease-Modifying Therapies in Pediatric MS.

Authors:  Marta Simone; Tanuja Chitnis
Journal:  Curr Treat Options Neurol       Date:  2016-08       Impact factor: 3.972

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.